Modelling dementia: Effects of scopolamine on memory and attention

https://doi.org/10.1016/0028-3932(88)90004-8Get rights and content

Abstract

Scopolamine, a muscarinic cholinergic antagonist, is capable of inducing transient memory impairment in normal subjects. Against the background of the cholinergic hypothesis of Alzheimer's disease (AD) the present study was designed to investigate the effects of low oral doses of scopolamine on a range of cognitive functions known or hypothesized to be affected in AD. Twenty healthy volunteers (18–48 yr) performed a battery of automated cognitive tasks under each of five treatments: oral scopolamine 0.3 mg, 0.6 mg, 1.2 mg; oral methylscopolamine 0.6 mg; placebo. Alongside analogous tests of verbal and non-verbal memory, the battery enabled assessments of a range of attentional functions: alerting, sustained attention, selective attention, and covert orientation. A profile of effects was observed within and beyond the realm of memory. While some functions were unaffected by the drug (e.g. alerting) and others were impaired at the highest dose (e.g. verbal learning) still others were affected in a linear dose-dependent manner (sustained attention; visual contrast sensitivity). These observations are discussed in the context of the “scopolamine model” of AD.

References (55)

  • W. Acker et al.

    Bexley Maudsley Automated Psychological Screening and Bexley Maudsley Category Sorting Test

    (1982)
  • D.A. Alexander

    Attention dysfunction in senile dementia

    Psychol. Rep.

    (1973)
  • D.A. Allport et al.

    Perceptual integration and post-categorical filtering

  • A.D. Baddeley

    Working memory

    Phil. Trans. R. Soc. Lond. B.

    (1983)
  • A. Bond et al.

    The use of analogue scales in rating subjective feelings

    Br. J. med. Psychol.

    (1974)
  • D.M. Bowen et al.

    Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

    Brain

    (1976)
  • E.D. Caine et al.

    Qualitative analysis of scopolamine-induced amnesia

    Psychopharmacology

    (1981)
  • T.J. Crow et al.

    An analysis of the learning deficit following hyoscine administration to man

    Br. J. Pharmac.

    (1973)
  • P. Davies

    Biochemical changes in Alzheimer's disease—senile dementia: neurotransmitters in senile dementia of the Alzheimer's type

  • D.A. Drachman et al.

    Human memory and the cholinergic system

    Archs Neurol.

    (1974)
  • C.D. Frith et al.

    The effects of intravenous diazepam and hyoscine upon human memory

    Q.J. exp. Psychol.

    (1984)
  • P.A. Fuld et al.

    Instrusions as a sign of Alzheimer dementia: chemical and pathological verification

    Ann. Neurol.

    (1982)
  • M.M. Ghoneim et al.

    Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory

    Psychopharmacologia

    (1975)
  • M.M. Ghoneim et al.

    Studies on human memory: the interactions of diazepam, scopolamine and physostigmine

    Psychopharmacology

    (1977)
  • D.R. Hinton et al.

    Optic-nerve degeneration in Alzheimer's disease

    New Eng. J. Med.

    (1986)
  • E. Hollander et al.

    Cholinergic approaches to the treatment of Alzheimer's disease

    Br. Med. Bull.

    (1986)
  • F.A. Huppert et al.

    Clinical and neuropsychological assessment of dementia

    Br. Med. Bull.

    (1986)

    • Cited by (0)

    ∗

    Present address: Department of Psychology, St James's University Hospital, Beckett Street, Leeds, LS9 7TF.

    View full text
    Copyright © 1988 Published by Elsevier Ltd.